145 related articles for article (PubMed ID: 1444557)
1. Changes in the plasma aminogram of parenterally fed infants treated with dexamethasone for bronchopulmonary dysplasia.
Ng PC; Brownlee KG; Kelly EJ; Henderson MJ; Smith M; Dear PR
Arch Dis Child; 1992 Oct; 67(10 Spec No):1193-5. PubMed ID: 1444557
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone increases plasma amino acid concentrations in bronchopulmonary dysplasia.
Williams AF; Jones M
Arch Dis Child; 1992 Jan; 67(1 Spec No):5-9. PubMed ID: 1536587
[TBL] [Abstract][Full Text] [Related]
3. Plasma amino acid concentrations in parenterally fed preterm infants.
Clark D; Henderson M; Smith M; Dear PR
Arch Dis Child; 1989 Jul; 64(7 Spec No):939-42. PubMed ID: 2505693
[TBL] [Abstract][Full Text] [Related]
4. A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants.
Zhu H; Tian Y; Cheng H; Zheng Y; Wang W; Bao T; Wu R; Tian Z
Int J Med Sci; 2021; 18(12):2581-2588. PubMed ID: 34104089
[No Abstract] [Full Text] [Related]
5. Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia.
Kari MA; Heinonen K; Ikonen RS; Koivisto M; Raivio KO
Arch Dis Child; 1993 May; 68(5 Spec No):566-9. PubMed ID: 8323356
[TBL] [Abstract][Full Text] [Related]
6. Effect of dexamethasone on leukocyte numbers and lymphocyte-blastogenic responses to mitogens in infants with bronchopulmonary dysplasia.
Moya FR; Becerra M; Leiva L; Sorensen RU
Clin Pediatr (Phila); 1993 Mar; 32(3):185-8. PubMed ID: 8453841
[No Abstract] [Full Text] [Related]
7. Amino acids in parenteral nutrition of preterm infants. Comparison of oral and parenteral supply.
Beganović N; Kok K; de Leeuw R; de Vries IJ; Schutgens R
Acta Paediatr Scand; 1983 May; 72(3):421-5. PubMed ID: 6410681
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Ng PC
Arch Dis Child; 1993 Mar; 68(3 Spec No):330-6. PubMed ID: 8466274
[No Abstract] [Full Text] [Related]
9. The effectiveness and side effects of dexamethasone in preterm infants with bronchopulmonary dysplasia.
Williams AF
Arch Dis Child; 1993 Sep; 69(3 Spec No):331. PubMed ID: 8215580
[No Abstract] [Full Text] [Related]
10. The use of dexamethasone in premature infants at risk for bronchopulmonary dysplasia or who already have developed chronic lung disease: a cautionary note.
Frank L
Pediatrics; 1991 Aug; 88(2):413-6. PubMed ID: 1741827
[No Abstract] [Full Text] [Related]
11. Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia.
Watts CL; Bruce MC
J Pediatr; 1992 Oct; 121(4):597-607. PubMed ID: 1403398
[TBL] [Abstract][Full Text] [Related]
12. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia.
Skinner AM; Battin M; Solimano A; Daaboul J; Kitson HF
Am J Perinatol; 1997 Oct; 14(9):539-46. PubMed ID: 9394163
[TBL] [Abstract][Full Text] [Related]
13. Basal and post-ACTH cortisol levels in preterm infants following treatment with dexamethasone.
Cronin CM; Dean H; MacDonald NT; Seshia MM
Clin Invest Med; 1993 Feb; 16(1):8-14. PubMed ID: 8385590
[TBL] [Abstract][Full Text] [Related]
14. [Function of the hypothalamo-hypophyseal-adrenal axis to corticotropin-releasing hormone test in premature infants with bronchopulmonary dysplasia].
Merz U; Pfäffle R; Peschgens T; Hörnchen H
Z Geburtshilfe Neonatol; 1997; 201(6):253-7. PubMed ID: 9491545
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone does not prevent catabolic side effects of dexamethasone in extremely low birth weight preterm infants with bronchopulmonary dysplasia--a pilot study.
Tonini G; Pahor T; Colonna F; de Vonderweid U
J Pediatr Endocrinol Metab; 1997; 10(3):291-4. PubMed ID: 9388821
[TBL] [Abstract][Full Text] [Related]
16. Effects of dexamethasone on blood pressure in premature infants with bronchopulmonary dysplasia.
Adelman RD
J Pediatr; 1998 Jan; 132(1):187. PubMed ID: 9470029
[No Abstract] [Full Text] [Related]
17. Adaptive regulation of amino acid metabolism on early parenteral lipid and high-dose amino acid administration in VLBW infants - a randomized, controlled trial.
Vlaardingerbroek H; Roelants JA; Rook D; Dorst K; Schierbeek H; Vermes A; Vermeulen MJ; van Goudoever JB; van den Akker CH
Clin Nutr; 2014 Dec; 33(6):982-90. PubMed ID: 24461877
[TBL] [Abstract][Full Text] [Related]
18. Effect of dexamethasone on protein metabolism in infants with bronchopulmonary dysplasia.
Van Goudoever JB; Wattimena JD; Carnielli VP; Sulkers EJ; Degenhart HJ; Sauer PJ
J Pediatr; 1994 Jan; 124(1):112-8. PubMed ID: 8283359
[TBL] [Abstract][Full Text] [Related]
19. Hypertrophic cardiomyopathy in preterm infants treated with methylprednisolone for bronchopulmonary dysplasia.
Dani C; Bertini G; Simone P; Rubaltelli FF
Pediatrics; 2006 May; 117(5):1866-7. PubMed ID: 16651362
[No Abstract] [Full Text] [Related]
20. Effect of dexamethasone on lymphocyte subpopulations in premature infants with bronchopulmonary dysplasia.
Parimi PS; Birnkrant DJ; Rao LV; Diaz G; Moore JJ
J Perinatol; 1999; 19(5):347-51. PubMed ID: 10685255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
